Maze Therapeutics, Inc. Common Stock (MAZE) stock news · $525.3M cap
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
This MAZE news page leads with what Maze Therapeutics, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for MAZE yet. We will not pad this page with generic market recap.
Latest reported MAZE revenue for 2026-03-31 was $20.0M. Net income was -$24.2M. MAZE currently screens at market cap $525.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MAZE stock page; for the tape open the quote page.
MAZE stock news FAQ
What are MAZE's latest revenue and net income?
Latest cached Maze Therapeutics, Inc. Common Stock (MAZE) revenue for Mar 31, 2026 was $20.0M. Net income was -$24.2M. Statements: https://lician.com/financials/maze
What is MAZE's market cap?
Maze Therapeutics, Inc. Common Stock (MAZE) market cap is $525.3M on the latest cached fundamentals snapshot.
What kind of company is MAZE?
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Where is MAZE stock news listed?
Cached stock news for Maze Therapeutics, Inc. Common Stock (MAZE) is listed at https://lician.com/news/maze. Filings: https://lician.com/sec/maze
Not investment advice.